Fever, Jaundice, and Right-Upper-Quadrant Pain

Learning objectives#

• Recognize suspected acute cholangitis through systemic inflammation, cholestasis, biliary obstruction, and illness severity rather than waiting for a complete classic triad.
• Distinguish common-duct infection and obstruction from acute cholecystitis, pancreatitis, hepatitis, malignant obstruction, and nonbiliary emergencies.
• Choose ultrasound, MRCP, endoscopic ultrasound, computed tomography, and ERCP according to the clinical question and the patient's stability.
• Coordinate sepsis treatment with definitive biliary source control, including alternatives when ERCP is unavailable or unsuccessful.
• Build post-crisis follow-up that addresses stone clearance, gallbladder management, stent removal, culture review, and recurrent-warning symptoms.

Initial presentation#

A 61-year-old woman arrives at an emergency department after 18 hours of worsening right-upper-quadrant and upper-central abdominal pain; the pain is steady rather than brief, radiates toward the right back, and is accompanied by shaking chills, nausea, and two episodes of vomiting. Her family noticed yellowing of her eyes that morning. She reports dark urine and lighter stool. There is no vomiting of blood, black stool, or diarrhea. There is no chest pressure, cough, painful urination, or recent travel.

Her history includes type 2 diabetes, hypertension, and gallstones found incidentally three years earlier. She has never had bile-duct surgery or pancreatitis. She takes several prescribed medicines but cannot recall their names because she left quickly, and she reports a severe rash after an antibiotic years ago, yet neither she nor the first electronic record can identify the agent. She drinks alcohol rarely and uses no herbal weight-loss product. There is no known viral hepatitis or chronic liver disease.

Temperature is 39.1 C, pulse 112 per minute, blood pressure 98/61 mm Hg, respiratory rate 23 per minute, and oxygen saturation 96 percent on room air. She is alert but answers more slowly than her family expects. Sclerae are jaundiced. Mucous membranes are dry. There is marked right-upper-quadrant tenderness without generalized rigidity. The gallbladder is not palpable. Lungs are clear, the heart rhythm is fast and regular, and there is no edema or focal neurologic deficit.

A trainee recognizes fever, jaundice, and right-upper-quadrant pain and labels the presentation "Charcot triad." Another proposes waiting for a magnetic resonance cholangiopancreatography appointment the next morning before contacting the endoscopy team; the immediate decision is whether the triad finishes the diagnosis, starts the reasoning, or is being allowed to hide a time-critical deterioration.

Problem representation#

This is an older adult with an acute febrile right-upper-quadrant pain syndrome, visible jaundice, possible altered mentation, relative hypotension, and a history that makes gallstone migration plausible. The working syndrome is infected biliary obstruction with evolving sepsis, most likely acute cholangitis from a common bile duct stone. The patient may already have organ dysfunction, and her blood pressure and mental state require repeated assessment rather than reassurance from a single measurement.

The classic symptom triad raises suspicion, but it neither measures severity nor identifies the obstructing cause. Some patients with cholangitis lack one or more elements. Hepatitis, liver abscess, and pancreatitis can produce overlapping features. So can cholecystitis and malignant obstruction. The near-term tasks are therefore parallel: stabilize physiology, obtain decision-relevant laboratory and microbiology data, start appropriate empiric antimicrobial therapy, identify biliary dilation or another source, and activate a pathway capable of urgent decompression.

Prioritized differential#

1. Acute cholangitis from choledocholithiasis#

Reasoning for: Fever and rigors support infection; jaundice and pale stool support impaired bile flow; right-upper-quadrant pain and known gallstones make a migrated stone plausible. Relative hypotension and slowed responses suggest that infection may be affecting organs. This combination makes cholangitis more than an incidental laboratory possibility.

Reasoning against or still uncertain: No imaging yet confirms duct dilation or a stone, and malignant or benign stricture can also obstruct the duct. A stone can pass before imaging. The diagnosis rests on the combined inflammatory, cholestatic, imaging, and clinical picture, not on direct stone visualization alone.

2. Acute calculous cholecystitis#

An obstructed cystic duct causes gallbladder inflammation and often fever and right-upper-quadrant tenderness. It can coexist with a common-duct stone. Marked jaundice is less typical for uncomplicated cholecystitis, so cholangitis, Mirizzi syndrome, or another obstruction needs explanation. Gallbladder wall thickening and pericholecystic fluid are also not perfectly specific, especially with systemic illness, low albumin, heart failure, or liver disease.

3. Gallstone pancreatitis#

Epigastric pain radiating to the back and vomiting make pancreatitis relevant. Serum lipase and imaging context can support it. Pancreatitis alone does not explain infected biliary obstruction, and urgent ERCP is not routine for gallstone pancreatitis without cholangitis or ongoing duct obstruction. The distinction changes whether endoscopy is an emergency source-control procedure.

4. Malignant or benign biliary stricture with secondary infection#

Pancreatic, ampullary, gallbladder, or bile-duct malignancy can cause painless or painful jaundice and can become infected after obstruction. Prior biliary surgery, chronic pancreatitis, primary sclerosing cholangitis, and indwelling stents create other stricture pathways. The abrupt pain and stone history favor choledocholithiasis, but unexplained weight loss, a mass, persistent narrowing, or failure to clear obstruction would redirect the workup after stabilization.

5. Acute hepatitis or drug-induced liver injury#

Viral, ischemic, and autoimmune liver injury can cause jaundice, nausea, fever, and aminotransferase elevation. So can alcohol-associated and medication-related liver injury. A predominantly hepatocellular biochemical pattern, relevant medicine or infection history, or absent duct dilation would raise these possibilities. Ischemic hepatitis can also follow shock rather than cause the initial syndrome.

6. Liver abscess or another intra-abdominal infection#

A liver abscess may cause fever, right-upper-quadrant pain, and abnormal liver tests. Perforated ulcer, appendicitis in a high position, pyelonephritis, or a subphrenic infection can mimic biliary disease, and cross-sectional imaging becomes important when ultrasound and the laboratory pattern do not explain the illness or when a complication is suspected.

7. Nonabdominal time-critical mimics#

Inferior myocardial ischemia, right-lower-lobe pneumonia, pulmonary embolism, and metabolic illness may present with upper abdominal symptoms. An ECG, cardiopulmonary examination, oxygenation, and symptom-directed testing prevent jaundice from becoming diagnostic tunnel vision. Visible jaundice makes biliary disease likely but does not make a second emergency impossible.

Focused history and examination#

History first determines danger and source. The clinician asks about confusion, fainting, and breathlessness. The questions cover reduced urine, cold or mottled skin, worsening weakness, and the pace of pain and fever. Bleeding, anticoagulant use, cardiopulmonary disease, kidney disease, and baseline function affect resuscitation and procedural risk.

Biliary questions include prior colicky pain, known stones, and pancreatitis. They include jaundice, endoscopy, and stents. They include altered surgical anatomy, transplant, strictures, and gallbladder or bile-duct procedures. Fever after a recent biliary procedure or an indwelling stent changes likely organisms and resistance; travel, raw-food history, immune status, and region of origin are considered only when they alter parasite or infection probability.

Every medicine, supplement, and last dose is reconciled. The team clarifies the reported antibiotic reaction, including timing and symptoms. The clarification covers mucosal involvement, breathing difficulty, and treatment. A vague allergy label should not be ignored, but neither should it automatically force an inferior regimen. Pharmacy records and family information are sought while a safe empiric choice is made.

The examination is repeated, not performed once. Mental state, airway protection, and respiratory effort reveal progression. So do oxygenation, blood pressure, and perfusion. So do temperature and urine output. Abdominal examination looks for focal tenderness, guarding, or a mass. It looks for gallbladder findings, distention, or peritonitis. Skin is assessed for jaundice, bruising, rash, and mottling. Cardiopulmonary and costovertebral findings help identify mimics and resuscitation constraints.

Diagnostic strategy#

Obtain immediate severity and mechanism data#

Two intravenous access routes, cardiac monitoring, and frequent vital signs are established. Tests include complete blood count; electrolytes; glucose; kidney function; bilirubin with liver biochemical tests; coagulation measures; and lipase. A blood gas and lactate help assess impaired perfusion and acid-base status but alone cannot diagnose or exclude sepsis, and blood cultures are obtained before antibiotics when this can occur promptly and without delaying treatment. IDSA guidance particularly supports cultures when intra-abdominal infection is accompanied by hypotension, tachypnea, delirium, resistant-organism concern, or suspected ascending cholangitis.

Urinalysis, pregnancy testing when biologically relevant, and troponin are selected from the history and examination. So are chest imaging, hepatitis studies, and toxin testing. A large undirected panel is not a substitute for source reasoning. Tumor markers are not emergency diagnostic tests for this presentation and can be misleading during obstruction and inflammation.

Image the right question#

Right-upper-quadrant ultrasound is the usual first biliary study. It can identify gallstones, gallbladder inflammation, bile-duct dilation, and some duct stones without radiation. A normal-caliber duct or unseen stone does not fully exclude recent or intermittent obstruction. Technical limits, early disease, prior surgery, and stone location affect sensitivity.

MRCP or endoscopic ultrasound can clarify an intermediate-probability duct stone in a stable person and can prevent purely diagnostic ERCP. Computed tomography is useful for complications, malignancy, or abscess. It is useful for pancreatitis, perforation, or an alternative diagnosis, although it may miss some stones. Nuclear gallbladder imaging answers a cholecystitis question when ultrasound is equivocal; it is not the next obligatory test when the dominant emergency is infected common-duct obstruction.

ERCP is different because it can drain the duct, remove a stone, and place a temporary stent. It also carries meaningful risks, including pancreatitis, bleeding, and infection. The risks include perforation, sedation complications, and failed access. In a stable patient with uncertainty, noninvasive confirmation may be appropriate. In a deteriorating patient with high-probability cholangitis, another confirmatory scan must not delay the therapeutic procedure or transfer needed for source control.

Progressive results and interpretation#

The first results show a white-cell count of 17.2 x 10^9/L, total bilirubin 6.4 mg/dL, alkaline phosphatase more than three times the upper reference limit, and moderate aminotransferase elevation. Creatinine is 1.7 mg/dL compared with 0.8 mg/dL six months earlier. Platelets are mildly reduced, the international normalized ratio is prolonged, and lactate is 3.1 mmol/L. Lipase is not substantially elevated. These findings support systemic inflammation, a cholestatic pattern, acute kidney injury, and impaired perfusion. They also raise procedural and medication-safety questions.

Ultrasound shows gallstones, a common bile duct measuring 11 mm, and mild intrahepatic duct dilation. The gallbladder is distended, but there is no clear wall defect or surrounding collection. No duct stone is seen. The absent stone image does not neutralize the dilated duct, cholestasis, and septic presentation; a passed stone is possible, but ongoing obstruction remains the safer working assumption until drainage or further evidence resolves it.

While imaging is being reviewed, blood pressure falls to 84/50 mm Hg. The patient becomes disoriented to place, and urine output is minimal. Carefully reassessed crystalloid does not restore adequate perfusion, so critical-care support and a vasopressor are initiated through the local protocol. This is now severe biliary infection with organ dysfunction and shock physiology. Calling the MRCP schedule is no longer the central task; securing urgent biliary decompression is.

The endoscopy and anesthesia teams perform urgent ERCP after resuscitation is underway. Purulent bile drains after duct access. A distal common-duct stone is removed, and a temporary stent is placed because edema and residual debris make immediate drainage security important. Bile and blood cultures later grow a susceptible enteric gram-negative organism. Hemodynamics, mental status, urine output, and bilirubin begin to improve over the next day; improvement supports the working diagnosis but does not erase the need to document complete clearance and a stent plan.

Management plan#

Treat sepsis and obstruction together#

Airway, breathing, circulation, mental state, and perfusion are treated while the biliary pathway is activated. Oxygen, fluids, vasopressors, and higher-acuity monitoring are used according to physiology and local protocols. Fluid is not given as an unexamined fixed volume: cardiac function, kidney function, pulmonary findings, perfusion response, and dynamic reassessment shape further administration.

Empiric intravenous antibiotics are started promptly for likely biliary infection. Selection covers expected enteric organisms. It is adjusted for community versus healthcare association, prior microbiology, and recent antibiotics. It is adjusted for immune status, local resistance, allergy details, and kidney and liver function. Exact agents and doses are intentionally omitted because they require the current local formulary, antibiogram, organ-function adjustment, and specialist or pharmacy verification. Antibiotics are narrowed when culture and source-control information permit. They support source control; they do not mechanically open an obstructed duct.

ASGE guidance favors endoscopic over percutaneous drainage when feasible and suggests decompression within 48 hours, with greater urgency driven by instability, and it also supports combining drainage with stone therapy when the patient can tolerate it. A patient too unstable for prolonged intervention may receive decompression alone, with definitive clearance later. The procedure, sedation, bleeding, and anatomy risks are balanced against the immediate danger of persistent infection.

Use an alternative source-control route when needed#

If ERCP is unavailable within the needed window, the patient requires transfer to a capable center rather than passive observation. If conventional ERCP fails or anatomy prevents access, interventional radiology, advanced endoscopy, and surgery decide together. They choose among percutaneous drainage, alternative endoscopic access, or operative management. The best route depends on anatomy, obstruction level, coagulopathy, local skill, and physiologic stability.

After infection and organ dysfunction improve, the team confirms duct clearance and records the exact plan for temporary-stent removal or exchange. A retained stent without ownership can cause recurrent obstruction and infection. Because gallstones caused this event, surgery evaluates definitive gallbladder management during the same episode of care or after a clinically justified delay. Frailty, anatomy, cardiopulmonary risk, patient preference, and residual infection determine timing; "ERCP completed" is not the same as "future biliary risk addressed."

Escalation, referral, and safety net#

Immediate critical-care, gastroenterology, and surgical escalation is required for hypotension, altered mentation, hypoxemia, rising lactate with impaired perfusion, acute kidney injury with oliguria, coagulopathy, thrombocytopenia, respiratory failure, or any other new organ dysfunction. Generalized peritonitis, perforation, uncontrolled bleeding, gallbladder necrosis, or another surgical abdomen requires urgent operative assessment.

Transfer is time-critical when the current hospital cannot provide the needed endoscopic, radiologic, surgical, anesthesia, or intensive-care support. Transfer discussions state the working diagnosis, organ dysfunction, and resuscitation. They state antimicrobial timing, imaging, and anticoagulants. They state allergy uncertainty and whether a duct or gallbladder intervention is needed. A patient should not remain at a lower-capability site merely to complete low-yield imaging.

After discharge, fever, shaking chills, or recurrent jaundice triggers emergency reassessment. So does dark urine, pale stool, or worsening upper abdominal pain. So does persistent vomiting, fainting, or confusion. So does breathlessness or inability to hydrate. A person with a biliary stent receives an exact removal or exchange date, the responsible service, and a backup route if scheduling fails.

Communication, shared decisions, and equity#

A concise explanation is: "The findings suggest that bile is not draining normally and infection may be trapped above the blockage. Antibiotics treat bacteria, but drainage may be needed to remove the source. Your blood pressure, kidney function, and alertness make this urgent."

Consent for ERCP covers its therapeutic purpose, uncertainty about the cause, and possible stone removal or stenting. It covers anesthesia, common complications, alternatives, and the greater risk of leaving severe obstruction untreated. When shock impairs decision-making capacity, the team uses the legally appropriate emergency and surrogate process while preserving the patient's known values. Reassessment includes the patient once capacity returns.

Language access is a safety intervention. A qualified interpreter is used for history, allergy clarification, consent, and the stent follow-up plan rather than relying on relatives for technical interpretation. Jaundice may be less visually obvious across skin tones, so clinicians use sclerae, history, laboratory testing, and the full examination rather than a color-based shortcut.

Rural distance, transfer cost, and insurance can delay emergency drainage or later stent removal. So can immigration concerns, disability access, caregiving, and paid-leave limitations. The team addresses transport and scheduling before discharge and does not label an unsafe return plan as patient nonadherence. Dietary blame is avoided: gallstone disease has multiple contributors, and the immediate infection is not evidence of a moral failure or a single meal choice.

Follow-up and contingencies#

During admission, the team trends symptoms, mental state, and blood pressure. It trends urine output, kidney function, and bilirubin and liver tests. It trends blood counts, coagulation, and culture results. Persistent fever or organ dysfunction after apparently successful drainage prompts review. The review looks for incomplete clearance, a blocked stent, or resistant infection. It looks for liver abscess, gallbladder complication, or pancreatitis. It looks for perforation or a different source.

Antibiotic duration is reassessed after source control rather than copied from a fixed habit. The documented plan identifies culture follow-up, de-escalation, organ-function adjustments, and the stop decision. New diarrhea, rash, kidney injury, cytopenia, or other adverse effects prompt medicine review.

Before discharge, records reconcile whether the common duct is clear, whether a stent remains, who owns its removal, and whether cholecystectomy is planned. If narrowing persists after inflammation resolves, advanced imaging, repeat endoscopy, tissue sampling, or hepatobiliary review may be needed to exclude malignancy or benign stricture. Persistent cholestasis is not attributed indefinitely to a stone that was already removed.

The patient receives a plain-language summary, medication list, pending-result owner, surgical and endoscopy appointments, and emergency thresholds. The primary-care team receives the same plan. If an appointment is missed, the service uses agreed safe contact methods because an untracked temporary stent is a systems hazard, not merely an administrative detail.

Reasoning traps and alternative pathways#

• Waiting for the complete triad: Cholangitis can occur without all three classic symptoms. Severity and organ dysfunction matter more than pattern recognition alone.
• Treating the triad as proof: Other hepatobiliary and systemic diseases can overlap. Laboratory patterns, imaging, and response to source control refine the diagnosis.
• Equating no visible ultrasound stone with no obstruction: Duct dilation, cholestasis, a passed stone, small stones, and technical limitations must be considered together.
• Using MRCP as a ritual before ERCP: Noninvasive confirmation is valuable for uncertainty in stable patients, but it can become harmful delay in high-probability severe cholangitis.
• Calling antibiotics definitive treatment: Persistent infected obstruction often needs drainage.
• Performing diagnostic ERCP at low probability: ERCP has real harms; MRCP or endoscopic ultrasound can answer an intermediate-risk question without instrumenting the duct.
• Confusing cholecystitis and cholangitis: Cystic-duct and common-duct disease can coexist, but the required source-control procedure may differ.
• Forgetting the stent: Temporary drainage without a documented removal or exchange owner creates future infection risk.
• Stopping after the crisis: Gallstone clearance, gallbladder strategy, persistent-stricture evaluation, and culture follow-up complete the episode.

An alternative stable branch might use MRCP or endoscopic ultrasound before therapeutic ERCP. A patient with gallstone pancreatitis but no cholangitis or ongoing obstruction would not automatically receive urgent ERCP. A patient with malignant hilar obstruction or surgically altered anatomy could require a different drainage route. A patient with isolated cholecystitis might need early cholecystectomy or, if surgery is temporarily unsafe and gallbladder sepsis persists, gallbladder drainage rather than common-duct treatment.

Evidence limits and what could change#

The timing and route evidence for cholangitis drainage includes observational data, heterogeneous severity definitions, and conditional recommendations. ASGE favors ERCP and drainage within 48 hours, while the patient's physiology can justify intervention much sooner. Tokyo Guidelines offer diagnostic and severity frameworks, but a score does not replace repeated bedside assessment or local procedural judgment.

Ultrasound, MRCP, endoscopic ultrasound, CT, and ERCP answer different questions. Their performance varies with operator, anatomy, stone size, and timing. Liver biochemical patterns overlap. A transient aminotransferase surge can occur with stone passage, and severe sepsis can alter multiple results. No isolated threshold should overrule a deteriorating patient.

Antimicrobial selection changes with geography, healthcare association, and prior organisms. It changes with allergies, organ function, and local resistance. The clinical outcome would change if the patient had an indwelling stent, transplant, altered anatomy, pregnancy, anticoagulation, severe cardiopulmonary disease, a malignant stricture, or a care preference that limited invasive support. Those differences require specialist review rather than a copied pathway.

Key points#

• Suspected cholangitis is built from systemic inflammation, cholestasis, biliary evidence, and severity; the classic triad is neither required nor sufficient.
• Stabilization, cultures when appropriate, antibiotics, imaging, and activation of source control proceed in parallel.
• Ultrasound is usually first-line imaging, while MRCP or endoscopic ultrasound can clarify uncertainty in stable patients and avoid unnecessary diagnostic ERCP.
• Severe or worsening cholangitis requires urgent biliary decompression; antibiotics cannot reliably overcome an infected obstructed duct.
• Safe closure includes culture review, confirmation of duct clearance, ownership of stent removal, and a definitive gallstone or stricture plan.